Hirsch MS - Search Results

1

In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.

Kollmann C, Tremblay C, Giguel F, Chou TC, Hirsch MS. Kollmann C, et al. Among authors: hirsch ms. Antivir Ther. 2001 Jun;6(2):143-4. Antivir Ther. 2001. PMID: 11491419 No abstract available.

2

In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs.

Rusconi S, Merrill DP, La Seta Catamancio S, Citterio P, Bulgheroni E, Croce F, Chou TC, Yang OO, Herrmann SH, Galli M, Hirsch MS. Rusconi S, et al. Among authors: hirsch ms. Antivir Ther. 2000 Sep;5(3):199-204. Antivir Ther. 2000. PMID: 11075940 Free article.

3

Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro.

Tremblay CL, Giguel F, Kollmann C, Guan Y, Chou TC, Baroudy BM, Hirsch MS. Tremblay CL, et al. Among authors: hirsch ms. Antimicrob Agents Chemother. 2002 May;46(5):1336-9. doi: 10.1128/AAC.46.5.1336-1339.2002. Antimicrob Agents Chemother. 2002. PMID: 11959565 Free PMC article.

4

Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection.

Tremblay CL, Hicks JL, Sutton L, Giguel F, Flynn T, Johnston M, Sax PE, Walker BD, Hirsch MS, Rosenberg ES, D'Aquila RT. Tremblay CL, et al. Among authors: hirsch ms. AIDS. 2003 May 2;17(7):1086-9. doi: 10.1097/00002030-200305020-00021. AIDS. 2003. PMID: 12700462

5

Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitro.

Tremblay CL, Poulin DL, Hicks JL, Selliah S, Chamberland A, Giguel F, Kollmann CS, Chou TC, Dong H, Hirsch MS. Tremblay CL, et al. Among authors: hirsch ms. Antimicrob Agents Chemother. 2003 Nov;47(11):3644-6. doi: 10.1128/AAC.47.11.3644-3646.2003. Antimicrob Agents Chemother. 2003. PMID: 14576137 Free PMC article.

6

TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro.

Tremblay CL, Giguel F, Chou TC, Dong H, Takashima K, Hirsch MS. Tremblay CL, et al. Among authors: hirsch ms. Antivir Ther. 2005;10(8):967-8. Antivir Ther. 2005. PMID: 16430202 No abstract available.

7

Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro.

Merrill DP, Moonis M, Chou TC, Hirsch MS. Merrill DP, et al. Among authors: hirsch ms. J Infect Dis. 1996 Feb;173(2):355-64. doi: 10.1093/infdis/173.2.355. J Infect Dis. 1996. PMID: 8568296

8

Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro.

Merrill DP, Manion DJ, Chou TC, Hirsch MS. Merrill DP, et al. Among authors: hirsch ms. J Infect Dis. 1997 Jul;176(1):265-8. doi: 10.1086/517263. J Infect Dis. 1997. PMID: 9207379

9

Interactions among combinations of two and three protease inhibitors against drug-susceptible and drug-resistant HIV-1 isolates.

Tremblay C, Merrill DP, Chou TC, Hirsch MS. Tremblay C, et al. Among authors: hirsch ms. J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):430-6. doi: 10.1097/00126334-199912150-00002. J Acquir Immune Defic Syndr. 1999. PMID: 10961603

10

Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.

Tremblay CL, Kollmann C, Giguel F, Chou TC, Hirsch MS. Tremblay CL, et al. Among authors: hirsch ms. J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):99-102. doi: 10.1097/00042560-200010010-00001. J Acquir Immune Defic Syndr. 2000. PMID: 11103038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters